6 Drug Manufacturers - Specialty & Generic companies are scored. Their average composite is 63.1, and 1 is in the A range (76+). The leader is Ironwood Pharmaceuticals Inc. (IRWD) at 76.7 (A-). This industry belongs to the Healthcare sector.
| # | Company | Composite | Grade | Industry opportunity | Stock selection | KPI momentum | Catalyst watch | Price | Expansion | Quality | Trend | Valuation gap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ironwood Pharmaceuticals Inc. (IRWD) | 76.7 | A- | 74 | 86 | 86 | 77 | 93 | 77 | 93 | 44 | -66.6% |
| 2 | Viatris Inc. (VTRS) | 63.9 | B- | 74 | 81 | 78 | 78 | 64 | 23 | 21 | 70 | -13.1% |
| 3 | Teva Pharmaceutical Industries Ltd. ADR (TEVA) | 63.5 | B- | 74 | 80 | 78 | 75 | 54 | 47 | 43 | 79 | -29.4% |
| 4 | United Therapeutics Corp. (UTHR) | 62.7 | B- | 74 | 66 | 72 | 54 | 47 | 44 | 83 | 51 | -10.5% |
| 5 | Haleon plc ADR (HLN) | 60.7 | B- | 74 | 82 | 84 | 73 | 64 | 29 | 62 | 37 | +4.3% |
| 6 | Zoetis Inc. (ZTS) | 51.2 | C | 74 | 58 | 29 | 71 | 70 | 14 | 74 | 9 | -2.7% |
The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.
General information, not investment advice.